Quintiles to merge with IMS Health

Skip to Navigation


  • Published: May 4, 2016
  • Author: Jon Evans
  • Source: Quintiles/IMS Health
  • Channels: Proteomics & Genomics / Electrophoresis / Laboratory Informatics / Sample Preparation / Detectors / Ion Chromatography / Gas Chromatography / HPLC / Raman / NMR Knowledge Base / Infrared Spectroscopy / Atomic / MRI Spectroscopy / Base Peak / X-ray Spectrometry / UV/Vis Spectroscopy / Chemometrics & Informatics / Proteomics

The US contract research organization Quintiles has announced its merger with IMS Health, a US information and technology services company for the healthcare industry.

The combined company will be known as Quintiles IMS, bringing together Quintiles’ industry-leading product development skills with IMS Health’s rich, global information solutions. It will have a market capitalization of over $17 billion and employ 50,000 people in more than 100 countries; in 2015, the two companies had a joint revenue of $7.2 billion.

“This combination addresses life-science companies’ most pressing needs: to transform the clinical development of innovative medicines, demonstrate the value of these medicines in the real world, and drive commercial success,” said Tom Pike, Quintiles’ chief executive officer. “We are bringing together two best-in-class leaders. I’m confident that together we will make our clients even more successful.”

“Together our solutions will enable differentiation in the CRO market, advance Real-World Evidence capabilities and deliver comprehensive commercial solutions for our clients,” said Ari Bousbib, chairman and chief executive officer of IMS Health. “This powerful combination brings together leading technology and analytics with deep scientific expertise delivered on a global scale by our 50,000 immensely talented professionals in more than 100 markets. Our combined business will accelerate growth, yield greater operating efficiencies and provide more flexibility for future expansion.”

The combined company expects to maintain dual headquarters in Danbury, Connecticut, and Research Triangle Park, North Carolina. Bousbib will become chairman and chief executive officer of the merged company, with Pike becoming vice chairman. The companies expect the merger to be finalized by the second half of 2016.

Social Links

Share This Links

Bookmark and Share


Suppliers Selection
Societies Selection

Banner Ad

Click here to see
all job opportunities

Most Viewed

Copyright Information

Interested in separation science? Visit our sister site separationsNOW.com

Copyright © 2019 John Wiley & Sons, Inc. All Rights Reserved